Merck Continues to Make Hundre...
Sales of Merck’s measles vaccine, the MMR combo vaccine that also includes mumps and rubella, continues to soar as Merck reported this week that in the second quarter of 2019, sales for the measles vaccine were 58% higher than the year before, at $675 million.
read more
Follow Us!